At
Pharmidex, we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers.
This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases.
Through our cutting-edge preclinical services, including:
- PK/ADME studies
- CNS penetration & efficacy models
- in vivo/in vitro pharmacology
- bioanalytical and regulatory support
๏ปฟ
we contribute to the development of safer, more effective therapies for blood cancers.
๐งฌ We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments.
โค๏ธ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure.
๐ Learn more and support the cause: https://www.dkms.org.uk



